Progressive changes in schizophrenia: Do they exist and what do they mean?

Restorative Neurology and Neuroscience

Volumn 12, Issue 2-3, 1998, Pages 175-184

  Anderson, J E ^a   O'Donnell, B F ^a   McCarley, R W ^a   Shenton, M E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Brain; ERP; Functional and Structural Changes; MRI; Neurodegenerative; Neurodevelopmental; Schizophrenia

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; BRAIN SIZE; COMPUTER ASSISTED TOMOGRAPHY; EVOKED AUDITORY RESPONSE; HUMAN; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA;

EID: 0031821051     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Barta, P.E., Pearlson, G.D., Powers, R.E., Richards, S.S. and Tune, L.E. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia, Am. J. Psychiatry, 147 (1990) 1457-1462.
2. Benes, F.M. Myelination of cortical-hippocampal relays during late adolescence, Schizophr. Bull., 15 (1989) 585-593.
3. Benes, F.M., McSparren, J., Bird, E.D., SanGiovanni, J.P. and Vincent, S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients, Arch. Gen. Psychiatry, 48 (1991) 996-1001.
4. Bilder, R.M. Structure-function relations in schizophrenia: brain morphology and neuropsychology. In E.F Walker et al. (Eds), Progress in Experimental Personality and Psychopathology Research, Vol. 15, Springer, New York, 1992, pp. 183-251.
5. Bleuler, E. Dementia Praecox or the Group of Schizophrenias (H. Zinkin, trans.), International Universities Press, New York, 1911/1950.
6. Bleuler, M. The schizophrenic disorders: Long-term patient and family studies, Yale University Press, New Haven, 1978.
7. Bogerts, B., Ashtari, M., Degreef, G., Alvir, J.M., Bilder, R.M. and Lieberman, J.A. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia, Psychiatry Res. Neuroimaging, 35 (1990) 1-13.
8. Bogerts, B., Falkai, P., Greve, B., Schneider, T. and Pfeiffer, U. The neuropathology of schizophrenia: past and present, J. Hirnforsch., 34 (1993) 193-205.
9. Breier, A., Schreiber, J.L., Dyer, J. and Pickar, D. National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome, Arch. Gen. Psychiatry, 48 (1991) 239-246.
10. Coyle, J.T. The glutamatergic dysfunction hypothesis for schizophrenia, Harvard Rev. Psychiatry, 3 (1996) 241-253.
11. Crow, T.J. Molecular pathology of schizophrenia: more than one disease process?, Br. Med. J., 280 (1980) 66-69.
12. DeLisi, L.E., Hoff, A.L., Schwartz, J.E., Shields, G.W., Halthore, S.N., Gupta, S.M., Henn, F.A. and Anand, A.K. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study, Biol. Psychiatry, 29 (1991) 159-175.
13. DeLisi, L.E., Stritzke, P., Riordan, H., Holan, V., Boccio, A., Kushner M, McClelland, J., Van Eyl, O. and Anand, A. The timing of brain morphological change in schizophrenia and their relationship to clinical outcome, Biol. Psychiatry, 31 (1992) 241-254.
14. DeLisi, L.E., Tew, W., Xie, S., Hoff, A.L., Sakuma, M., Kushner, M., Lee, G., Shedlack, K., Smith, A.M. and Crimson, R. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings, Biol. Psychiatry, 38 (1995) 349-360.
15. DeLisi, L.E., Sakuma, M., Tew, W., Kushner, M., Hoff, A.L. and Crimson, R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res., 74 (1997) 129-140.
16. Dunlap, C.B. Dementia praecox: some preliminary observations on brains from carefully selected cases, and a consideration of certain sources of error, Am. J. Psychiatry, 80 (1924) 403-421.
17. Ellison, G. Competitive and non-competitive NMDA antagonists induce similar limbic degeneration, Neuroreport., 5 (1994) 2688-2692.
18. Farber, N.B., Price., M.T., Labruyere, J., Fuller, T.A. and Olney, J.W. Age dependency of NMDA antagonist neurotoxicity, Soc. Neurosi. Abstr., 18 (1992) 1148.
19. Fenton, W.S. and McGlashan, T.H. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course, Arch. Gen. Psychiatry, 48 (1991) 978-986.
20. Fenton, W.S., Wyalt, R.J. and McGlashan, T.H. Spontaneous dyskinesia in schizophrenia [Abstract], Schizophr. Res., 15 (1995) 207.
21. Ford, J., Mathalon, D.H., Isaaks, B.G., Lim, K.O. and Pfefferbaum, A. P300 amplitude in schizophrenia is inversely related to duration of illness, Fifth International Congress on Schizophrenia Research, Warmsprings, VA, 1995.
22. Gadian, D.G. and Radda, G.K. NMR studies of tissue metabolism, Annu. Rev. Biochem., 50 (1981) 69-83.
23. Goldberg, T.E., Ragland, J.D., Torrey, E.F., Gold, J.M., Bigelow, L.B. and Weinberger, D.R. Neuropsychological assessment of monozygotic twins discordant for schizophrenia, Arch. Gen. Psychiatry, 47 (1990) 1066-1072.
24. Goldberg, T.E., Hyde, T.M., Kleinman, J.E. and Weinberger, D.R. Course of schizophrenia: neuropsychological evidence for a static encephalopathy, Schizophr. Res., 19 (1993) 797-804.
25. Goodin, D.S., Squires, K.C., Henderson, B.H. and Starr, A. Age related variations in evoked potentials to auditory stimuli in normal subjects, Electroenceph. Clin. Neurophysiol., 44 (1978) 447-458.
26. Grunze, H.C.R., Rainnie, D.G., Hasselmo, M.E., Barkai, E., Hearn, E.F., McCarley, R.W. and Greene, R.W. NMDA-dependent modulation of CAl local circuit inhibition, J. Neurosci., 16 (1996) 2034-2043.
27. Harding, C.M., Brooks, W.W., Ashikaga, T., Strauss, J.S. and Breier, A. The Vermont longitudinal study of persons with severe mental illness. II. Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia, Am. J. Psychiatry, 144 (1987) 727-735.
28. Hargreaves, R.J., Rigby, M., Smith, D., Hill, R.G. and Iversen, L.L. Competitive as well as uncompetitive NMDA receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism, Neurochem. Res., 18 (1993) 1263-1269.
29. Haug, J. O. Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients, Acta. Psychtatr. Scand., 66 (1982) 374-383.
30. Hegarty, J.D., Baidessarini, R.J., Tohen, M., Waternaux, C. and Oepen, G. One hundred years of schizophrenia: a meta-analysis of the outcome literature, Am. J. Psychiatry, 141 (1994) 1409-1416.
31. Hoffman, W.F. and Casey, D.E. Computed tomographic evaluation of patients with tardive dyskinesia: A review, Schizophr. Res., 5 (1991) 1-12.
32. Huber, G., Gross, G. and Schuttler, R. A long-term follow-up study of schizophrenia: psychiatric course of illness and prognosis, Acta. Psychiatr. Scand., 52 (1975) 49-57.
33. Illowsky, B.P., Juliano, D.M., Bigelow, L.B. and Weinberger, D.R. Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study, J. Neurol. Neurosurg. Psychiatr., 51 (1988) 209-213.
34. Jakob, H. and Beckman, H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics, J. Neural Transm., 65 (1986) 303-326.
35. Jaskiw, G.E., Juliano, D.M., Goldberg, T.E., Hertzman, M., Urow-Hamell and Weinberger, D.R. Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study, Schizophr. Res., 14 (1994) 23-28.
36. Kato, T., Shioiri, T., Murashita, J., Hamakawa, H., Inubushi, T. and Takahashi, S. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia, Psychiatry Res., 61 (1995) 151-160.
37. Keefe, R.S.E., Mohs, R.C., Losonczy, M.F., Davidson, M., Silverman, J.M., Kendler, K.S., Horvath, T.B., Nora, R. and Davis, K.L. Characterislics of very poor outcome in schizophrenia, Am. J. Psychiatry, 144 (1987) 889-895.
38. Kemali, D., Maj, M., Galderisi, S., Milici, N. and Salvati, A. Ventricle-to-brain ratio in schizophrenia: a controlled follow-up study, Biol. Psychiatry, 26 (1989) 756-759.
39. Kikinis, R., Shenton, M.E., Gerig, G., Hokama, H., Haimson, J., O'Donnell, B.F., Wible, C.G., McCarley, R.W. and Jolesz, F.A. Temporal lobe sulco-gyral pattern anomalies in schizophrenia: an in vivo MR three-dimensional surface rendering study, Neurosci. Lett., 182 (1994) 7-12.
40. Kraepelin, E. Dementia Praecox (E. Barclay and S. Barclay, trans.), Churchill Livingstone, Inc., New York, 1919/1971.
41. Lieberman, J., Bogerts, B., Degreef, G., Ashtari, M. and Lantos, G. Qualitative assessment of brain morphology in acute and chronic schizophrenia, Am. J. Psychiatry, 149 (1992) 784-794.
42. Liddle, P.F. and Crow, T.J. Age disorientation in chronic schizophrenia is associated with global intellectual impairment, Br. J. Psychiatry, 144 (1984) 193-199.
43. Loebel, A.D., Lieberman, J.A., Alvir, J.M., Mayerhoff, D.I., Geisler, S.H. and Szymanski, S.R. Duration of psychosis and outcome in first-episode schizophrenia, Am. J. Psychiatry, 149 (1992) 1183-1188.
44. Maier, M., Ron, M.A., Barker, G.J. and Tofts, P.S. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia., Psych. Med., 25 (1995) 1201-1209.
45. McCarley, R.W., Shenton, M.E., O'Donnell, B.R., Faux, S.F., Kikinis, R., Nestor, P.G. and Jolesz, F.A. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia, Arch. Gen. Psychiatry, 50 (1993) 190-197.
46. McCarley, R.W., Hsiao, J., Freedman, R., Pfefferbaum, A. and Donchin, E. Neuroimaging and the cognitive neuroscience of schizophrenia, Schizophr. Bull., 22 (1996) 703-726.
47. McCarley, R.W., O'Donnell, B.F., Niznikiewicz, M.A., Salisbury, D.F., Potts, G.F., Hirayasu, Y., Nestor, P.G. and Shenton, M.E. Update on electrophysiology, Int. J. Psychiatry 9 (1997) 373-386.
48. McGlashan, T.H. The Chestnut Lodge follow-up study, II: long-term outcome of schizophrenia and the affective disorders, Arch. Gen. Psychiatry, 41 (1984) 585-601.
49. Meltzer, H.Y. Clozapine: pattern of efficacy in treatment-resistant schizophrenia. In H.Y. Meltzer (Ed), Novel Antipsychotic Drugs, 1992, Raven Press, New York, pp. 33-46.
50. Mirsky, A.F., Kugelmass, S., Ingraham, L.J., Frenkel, E. and Nathan, M. Overview and summary: twenty-five-year followup of high risk children, Schizophr. Bull., 21 (1995) 227-239.
51. Nair, T.R., Christensen, J.D., Kingsbury, S.J., Kumar, N.G., Terry, W.M. and Garver, D.L. Progression of cerebroventricular enlargement and the subtyping of schizophrenia, Psychiatry Res. Neuroimaging, 74 (1997) 141-150.
52. Nasrallah, H.A., Olson, S.C., McCalley-Whitters, M., Chapman, S. and Jacoby, C.J. Cerebral ventricular enlargement in schizophrenia: a preliminary follow-up study, Arch. Gen. Psychiatry, 43 (1986) 157-159.
53. Nasrallah, H.A., Skinner, T.E., Schmalbrock, P. and Robitaille, P.-M. In vivo H-NMR spectroscopy of the limbic temporal lobe in patients with schizophrenia. In H.A. Nasrallah and J.W. Pettegrew (Eds), NMR Spectroscopy in Psychiatric Brain Disorders, American Psychiatric Press, Inc., Washington, D.C., 1995, pp. 1-44.
54. Nestor, P.G., Shenton, M.E., McCarley, R.W., Haimson, J., Smith, R.S., O'Donnell, B.F., Kimble, M., Kikinis, R. and Jolesz, F.A. Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia, Am. J. Psychiatry, 150 (1993) 1849-1855.
55. Nestor, P.G. and O'Donnell, B.F. The mind adrift: attention dysregulation in schizophrenia. In R. Parasuraman (Ed), The Attentive Brain, Massachusetts Institute of Technology Press, Cambridge, MA, (1998) 527-546.
56. Nopoulos, P., Swayze, V. and Andreasen, N.C. Pattern of brain morphology in patients with schizophrenia and large cavum septi pellucidi, J. Neuropsychiatry Clin. Neurosci., 8 (1996) 147-152.
57. O'Donnell, B.F., Squires, N.K., Martz, M.J., Chen, J.R. and Phay, A.J. Evoked potential and neuropsychological performance in Parkinson's disease, Biol. Psychiatry, 24 (1987) 23-37.
58. O'Donnell, B.F., Friedman, S., Squires, N.K., Maloon, A., Drachman, D.A. and Swearer, J.M. Active and passive P3 latency in dementia: relationship to psychometric, electroencephalographic, and computed tomographic measures, Neuropsychiatr. Neuropsychol. Behav. Neurol., 3 (1990) 164-179.
59. O'Donnell, B.F., Faux, S.F., McCarley, R.W., Kimble, M.O., Salisbury, D.F., Nestor, P.G., Kikinis, R., Jolesz, F.A. and Shenton, M.E. Increased rate of P300 latency prolongation with age in schizophrenia: electrophysiological evidence for a neurodegenerative process, Arch. Gen. Psychiatry, 52 (1995) 544-549.
60. Olney, J. W., Labruyere, J. and Price, M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs, Science 244 (1989) 1360-1362.
61. Olney, J.W and Farber, N.B. Glutamate receptor dysfunction and schizophrenia, Arch. Gen. Psychiatry, 52 (1995) 998-1007.
62. Park, S. and Holzman, P.S. Schizophrenics show spatial working memory deficits, Arch. Gen. Psychiatry, 49 (1992) 975-982.
63. Pettegrew, J.W., Keshavan, M.S., Panchalingam, K., Strychor, S., Kaplan, D.B., Gretta, M.G., and Allen, M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics, Arch. Gen. Psychiatry, 48 (1991) 563-568.
64. Polich, J. P300 in the evaluation of aging and dementia. In C.H.M. Brunia et al. (Eds), Event-Related Brain Research, Elsevier, Amsterdam, 1991, pp. 304-323.
65. Purohit, D.P., Davidson, M., Perl, D.P., Powchik, P., Haroutunian, V.H., Bierer, L.M., McCrystal, J., Losonczy, M. and Davis, K. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study, Biol. Psychiatry, 33 (1993) 255-260.
66. Renshaw, P.F., Sachs, G.S. and Gonzalez, R.G. In vivo MRS measurements of lithium levels in brain. In H.A. Nasrallah and J.W. Pettegrew (Eds), NMR Spectroscopy in Psychiatric Brain Disorders, American Psychiatric Press, Washington, D.C., 1995, pp. 179-198.
67. Robinson, M.B. and Coyle, J.T. Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application, FASEB J., 1 (1987) 446-455.
68. Shenton, M.E., Kikinis, R., Jolesz, F.A., Pollak, S.D., LeMay, M., Wible, C.G., Hokama, H., Martin, J., Metcalf, D., Coleman, M. and McCarley, R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia, N. Engl. J. Med, 327 (1992) 604-612.
69. Shenton, M.E., Wible, C.G. and McCarley, R.W. A review of magnetic resonance imaging studies of brain abnormalities in schizophrenia. In K. R. Rama Krishnan and P. M. Doraiswamy (Eds), Brain Imaging in Clinical Psychiatry, Marcel Dekker, New York, 1997, pp. 297-380.
70. Spohn, H.E. and Strauss, M.E. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia, Psychol. Bull., 98 (1989) 367-380.
71. Sponheim, S.R., Iacono, W.G. and Beiser, M. Stability of ventricular size after the onset of psychosis in schizophrenia, Psychiatry Res. Neumimaging, 40 (1991) 21-29.
72. Stanley, J.A., Williamson, P.C., Drost, D.J., Carr, T.J., Rylett, J., Malla, A. and Thompson, R.T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy, Arch. Gen. Psychiatry, 52 (1995) 399-406.
73. Swanson, C.L., Jr., Harper Mozley, L.M. and Gur, R.E. Positron emission tomography studies of cerebral metabolism and blood flow in schizophrenia. In K. R. Rama Krishnan and P.M. Doraiswamy (Eds), Brain Imaging in Clinical Psychiatry, Marcel Dekker, New York, 1997, pp. 401-424.
74. Tachibana, H., Aragane, K., Kawabata, K. and Sugita, M. P3 latency change in aging and Parkinson disease, Arch. Neurol., 54 (1997) 296-302.
75. Tsai, G.C. and Coyle, J.T. N-Acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol., 46 (1995) 531-540.
76. Tsuang, M.T., Woolson, R.F. and Fleming, J.A. Long-term outcome of major psychosis: schizophrenic and affective disorders compared with psychiatrically symptom-free surgical conditions, Arch. Gen. Psychiatry, 39 (1979) 1295-1301.
77. Vita, A., Sacchetti, E., Valvoassori, G. and Cazzullo, C.L. Brain morphology in schizophrenia: a 2- to 5-year CT scan follow-up study, Acla. Psychiatr. Scand., 78 (1988) 618-621.
78. Vita, A., Giobbio, G.M., Dieci, M., Garbarini, M., Morganti, C., Comazzi, M. and Invernizzi, G. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia., Biol. Psychiatry, 35 (1994) 960-962.
79. Walker, E., Savoie, T. and Davis, D. Neuromotor precursors of schizophrenia, Schizophr. Bull., 20 (1994) 441-451.
80. Welch, M.J. and Correa, G.A. PCP intoxication in young children and infants. Clin. Pediatr., 19 (1980) 511-514.
81. Woods, B.T., Yurgelun-Todd, D., Benes, F.M., Frankenburg, F.R., Pope, H.G., Jr. and McSparren, J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation with clinical course, Biol. Psychiatry, 27 (1990) 341-352.
82. Zipursky, R.B., Lim, D.O., Sullivan, E.V., Brown, B.W. and Pfefferbaum, A. Widespread cerebral gray matter volume deficits in schizophrenia, Arch. Gen. Psychiatry, 49 (1992) 195-205.